Cancer Genetics Appoints New Member to Board of Directors

By Italia on July 24 2013

Keith Brownlie, a former audit partner at Ernst & Young and its former Life Science Industry Leader for the New York metro area, will become a member of the board’s audit committee    RUTHERFORD, NJ, July 24, 2013 — Cancer Genetics, Inc. (OTCQB: CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, […]

Continue Reading

Cancer Genetics Launches New Genetic Test For Cervical Cancer Management

By Jamie on July 23 2013

A published research study, led in collaboration with the National Cancer Institute, highlights the relevance of FHACT™ in screening women with high risk of cervical cancer. RUTHERFORD, NJ, July 23, 2013 — Cancer Genetics, Inc. (OTCQB: CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, launched its proprietary cervical cancer test and […]

Continue Reading